Peter Boan
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
- Parvovirus B19 Infection Studies
- Transplantation top 10%
Papers in
- Epidemiology 25
- Cytomegalovirus and herpesvirus research 8
- Fungal Infections and Studies 6
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Herpesvirus Infections and Treatments 3
-
- Antifungal resistance and susceptibility 9
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 5
- Co-authors
- Melanie Lavender (6 shared papers)Todd M. Pryce (7 shared papers)Christopher H. Heath (3 shared papers)Jérémy Wrobel (5 shared papers)Geoffrey W. Coombs (4 shared papers)Aron Chakera (2 shared papers)Dianne Gardam (3 shared papers)James O. Robinson (3 shared papers)
- Journals
- BMC Infectious Diseases (5 papers)Pathology (3 papers)Journal of Chemotherapy (3 papers)Transplantation (2 papers)Open Forum Infectious Diseases (2 papers)
- Partner nations
- AustraliaUnited StatesSingapore
In The Last Decade
Peter Boan
45 papers receiving 450 citations
Peers
Comparison fields: 5 of 75
- Infectious Diseases 176
- Transplantation 23
- Epidemiology 230
- Drug Discovery 1
- Applied Microbiology and Biotechnology 7
Countries citing papers authored by Peter Boan
This map shows the geographic impact of Peter Boan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Boan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Boan more than expected).
Fields of papers citing papers by Peter Boan
This network shows the impact of papers produced by Peter Boan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Boan. The network helps show where Peter Boan may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Boan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 48 | |
| 2 | 2021 | 36 | |
| 3 | 2015 | 32 | |
| 4 | 2016 | 32 | |
| 5 | 2023 | 31 | |
| 6 | 2015 | 29 | |
| 7 | 2019 | 22 | |
| 8 | 2016 | 19 | |
| 9 | 2018 | 17 | |
| 10 | 2019 | 14 | |
| 11 | 2012 | 13 | |
| 12 | 2021 | 12 | |
| 13 | 2019 | 11 | |
| 14 | 2017 | 10 | |
| 15 | 2016 | 10 | |
| 16 | 2019 | 9 | |
| 17 | 2023 | 9 | |
| 18 | 2020 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2021 | 7 |
About Peter Boan
Peter Boan is a scholar working on Epidemiology, Infectious Diseases, Oncology, Surgery and Molecular Biology, having authored 49 papers that have together received 455 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (9 papers), Cytomegalovirus and herpesvirus research (8 papers), Fungal Infections and Studies (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), SARS-CoV-2 detection and testing (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Polyomavirus and related diseases (3 papers) and Herpesvirus Infections and Treatments (3 papers). The work is most often cited by research in Infectious Diseases (176 citations), Transplantation (23 citations), Epidemiology (230 citations), Drug Discovery (1 citation) and Applied Microbiology and Biotechnology (7 citations). Peter Boan has collaborated with scholars based in Australia, United States and Singapore. Frequent co-authors include Melanie Lavender, Todd M. Pryce, Christopher H. Heath, Jérémy Wrobel, Geoffrey W. Coombs, Aron Chakera, Dianne Gardam, James O. Robinson, James Flexman and Ashley Irish. Their work appears in journals such as BMC Infectious Diseases, Pathology, Journal of Chemotherapy, Transplantation and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.